This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: J Keith Killian: Innovator in Cancer Prognosis
Introduction
J Keith Killian is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of cancer prognosis through his innovative research and inventions. His work focuses on utilizing the M6P/IGF-II receptor to assess cancer prognosis, which has the potential to improve patient outcomes.
Latest Patents
J Keith Killian holds a patent titled "Cancer prognosis with the M6P/IGF-II receptor." This invention relates to a method of assessing the prognosis of a patient using the M6P/IGF-II receptor. His patent is a testament to his dedication to advancing cancer research and improving diagnostic methods.
Career Highlights
Killian is affiliated with Duke University, where he continues to engage in groundbreaking research. His work at this prestigious institution has allowed him to explore innovative solutions in the medical field, particularly in cancer prognosis.
Collaborations
Throughout his career, J Keith Killian has collaborated with esteemed colleagues, including Randy L Jirtle and Timothy A Jamieson. These collaborations have further enriched his research and contributed to the advancement of cancer prognosis methodologies.
Conclusion
J Keith Killian's contributions to cancer prognosis through his patent and research at Duke University highlight his commitment to improving healthcare outcomes. His innovative approach using the M6P/IGF-II receptor represents a significant step forward in cancer diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile